CS214766B2 - Method of making the pyrrolidine amids - Google Patents

Method of making the pyrrolidine amids Download PDF

Info

Publication number
CS214766B2
CS214766B2 CS765174A CS517476A CS214766B2 CS 214766 B2 CS214766 B2 CS 214766B2 CS 765174 A CS765174 A CS 765174A CS 517476 A CS517476 A CS 517476A CS 214766 B2 CS214766 B2 CS 214766B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
defined above
carbon atoms
compound
hydrogen
Prior art date
Application number
CS765174A
Other languages
Czech (cs)
English (en)
Inventor
Giorgio Pifferi
Mario Pinza
Original Assignee
Isf Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isf Spa filed Critical Isf Spa
Publication of CS214766B2 publication Critical patent/CS214766B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
CS765174A 1975-08-13 1976-08-09 Method of making the pyrrolidine amids CS214766B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT26326/75A IT1045043B (it) 1975-08-13 1975-08-13 Derivati pirrolidinici

Publications (1)

Publication Number Publication Date
CS214766B2 true CS214766B2 (en) 1982-05-28

Family

ID=11219233

Family Applications (1)

Application Number Title Priority Date Filing Date
CS765174A CS214766B2 (en) 1975-08-13 1976-08-09 Method of making the pyrrolidine amids

Country Status (27)

Country Link
US (1) US4118396A (da)
JP (1) JPS5822034B2 (da)
AR (1) AR212176A1 (da)
AT (1) AT353783B (da)
AU (1) AU506651B2 (da)
BE (1) BE845099A (da)
CA (1) CA1077947A (da)
CH (1) CH624935A5 (da)
CS (1) CS214766B2 (da)
DD (1) DD127966B3 (da)
DE (1) DE2635853C2 (da)
DK (1) DK156055C (da)
ES (1) ES450643A1 (da)
FI (1) FI62290C (da)
FR (1) FR2320741A1 (da)
GB (1) GB1550160A (da)
HU (1) HU173742B (da)
IN (1) IN144871B (da)
IT (1) IT1045043B (da)
MX (1) MX4717E (da)
NL (1) NL179052C (da)
NO (1) NO146909C (da)
NZ (1) NZ181726A (da)
PL (1) PL101471B1 (da)
SE (1) SE420599B (da)
SU (1) SU663302A3 (da)
YU (1) YU40147B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1075280B (it) 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
IT1075564B (it) 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
GB1580559A (en) * 1977-11-24 1980-12-03 Wyeth John & Brother Ltd Amide cerivatives
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
IT1131959B (it) * 1979-08-09 1986-06-25 Hoffmann La Roche Derivati pirrolidinici
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
IT1206699B (it) * 1984-02-27 1989-04-27 Isf Spa Procedimento per preparare derivati di pirrolidone.
CH666483A5 (de) * 1985-01-16 1988-07-29 Lonza Ag Verfahren zur herstellung von thiotetronsaeure.
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
EP0223328B1 (en) 1985-07-26 1992-01-29 Denki Kagaku Kogyo Kabushiki Kaisha Process for producing oxiracetam
CH668423A5 (de) * 1986-06-19 1988-12-30 Lonza Ag Verfahren zur herstellung von 4-alkoxy-3-pyrrolin-2-onen.
HU195773B (en) * 1985-09-24 1988-07-28 Lonza Ag Process for preparing alkyl esters of 4-alkoxy-3-pyrrolin-2-on-1-yl-acetic acid
IL80071A0 (en) * 1985-09-24 1986-12-31 Lonza Ag Pyrrolidine acetamide derivatives
US4677114A (en) * 1985-11-22 1987-06-30 Warner-Lambert Company Pyrrolidone-2 derivatives and pharmaceutical compositions thereof
CH668424A5 (de) * 1986-06-26 1988-12-30 Lonza Ag 4-benzyloxy-3-pyrrolin-2-on-l-yl-acetamid, dessen herstellung und verwendung.
CH668422A5 (de) * 1986-06-26 1988-12-30 Lonza Ag 4-benzyloxy-3-pyrrolin-2-on, dessen herstellung und verwendung zur synthese von tetramsaeure.
IT1224168B (it) * 1986-08-01 1990-09-26 Finanziaria R F Spa Ora Finanz Derivati del pirrolidin-2-one ad attivita' nootropa
CH667655A5 (de) * 1986-09-24 1988-10-31 Lonza Ag Verfahren zur herstellung von 4-alkoxy-2(5h)-thiophenonen.
CH670644A5 (da) * 1986-12-18 1989-06-30 Lonza Ag
US5202345A (en) * 1987-08-19 1993-04-13 Shionogi & Co., Ltd. Carbamoylpyrrolidone derivatives and drugs for senile dementia
CA1305148C (en) * 1987-08-19 1992-07-14 Hiromu Matsumura Carbamoylpyrrolidone derivatives and drugs for senile dementia
DE3813416A1 (de) * 1988-04-21 1989-11-02 Hoechst Ag 3,4-dihydroxypyrrolidin-2-on-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
JP2660201B2 (ja) * 1988-08-05 1997-10-08 塩野義製薬株式会社 新規ピロロ［１，４］ベンゾジアゼピン誘導体および老人性痴呆薬
JPH02115162A (ja) * 1988-09-06 1990-04-27 Lonza Ag ５―アルキルテトラム酸およびその製造方法
IL93051A0 (en) * 1989-01-17 1990-11-05 Hoffmann La Roche ((5-oxo-2-pyrrolidinyl)methyl)cyclohexaneacetamides,their preparation and pharmaceutical compositions containing them
FI95034C (fi) * 1989-03-15 1995-12-11 Lonza Ag Menetelmä 1,3-substituoidun tetrahydro-1H-tieno/3,4-d/-imidatsol-2(3H)-on-4-ylideenipentaanihappoesterin valmistamiseksi
CH680293A5 (da) * 1990-06-26 1992-07-31 Lonza Ag
JP3038032B2 (ja) * 1991-03-25 2000-05-08 日清製粉株式会社 血小板凝集抑制薬
WO2002053153A1 (fr) 2000-12-28 2002-07-11 Daiichi Pharmaceutical Co., Ltd. Medicaments permettant de traiter et de prevenir une douleur neurologique
EP1993998B1 (en) * 2005-12-07 2013-08-21 UCB Pharma, S.A. 3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses
DK3260118T3 (da) * 2008-10-16 2021-04-19 Univ Johns Hopkins Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
CA2789014C (en) * 2010-02-09 2019-01-15 Michela Gallagher Methods and compositions for improving cognitive function
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
CA2904767C (en) 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function
WO2016191288A1 (en) 2015-05-22 2016-12-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
CN105820102A (zh) * 2016-05-10 2016-08-03 武汉工程大学 奥拉西坦的合成工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011886B (de) * 1952-04-29 1957-07-11 Waldemar Kutscher Dr Ing Dr Me Verfahren zur Herstellung von Aminoalkylpyrrolen
GB1309692A (en) * 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
US3541111A (en) * 1968-05-08 1970-11-17 Du Pont Pyrrolinecarboxanilide compounds
US3577432A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-phenoxypyrrolidines

Also Published As

Publication number Publication date
JPS5822034B2 (ja) 1983-05-06
AU1679776A (en) 1978-02-16
FI62290C (fi) 1982-12-10
NO146909B (no) 1982-09-20
SE420599B (sv) 1981-10-19
FI762314A (da) 1977-02-14
DE2635853C2 (de) 1984-05-30
DK156055B (da) 1989-06-19
SU663302A3 (ru) 1979-05-15
DE2635853A1 (de) 1977-02-24
NZ181726A (en) 1978-09-20
NO762791L (da) 1977-02-15
NL179052C (nl) 1986-07-01
NO146909C (no) 1982-12-29
ES450643A1 (es) 1977-08-01
CA1077947A (en) 1980-05-20
DK156055C (da) 1989-12-04
BE845099A (fr) 1977-02-11
PL101471B1 (pl) 1978-12-30
AR212176A1 (es) 1978-05-31
US4118396A (en) 1978-10-03
IN144871B (da) 1978-07-22
SE7608938L (sv) 1977-02-14
DD127966A5 (de) 1977-10-26
FI62290B (fi) 1982-08-31
CH624935A5 (da) 1981-08-31
AU506651B2 (en) 1980-01-17
NL7608946A (nl) 1977-02-15
GB1550160A (en) 1979-08-08
ATA589476A (de) 1979-05-15
MX4717E (es) 1982-08-13
JPS5223072A (en) 1977-02-21
NL179052B (nl) 1986-02-03
YU40147B (en) 1985-08-31
FR2320741A1 (fr) 1977-03-11
DK365176A (da) 1977-02-14
HU173742B (hu) 1979-08-28
IT1045043B (it) 1980-04-21
YU196476A (en) 1982-06-30
DD127966B3 (de) 1983-03-30
AT353783B (de) 1979-12-10
FR2320741B1 (da) 1979-03-02

Similar Documents

Publication Publication Date Title
CS214766B2 (en) Method of making the pyrrolidine amids
DE60204718T2 (de) 3-substituierte oxindol beta 3 agonisten
DE69923692T2 (de) Wachstumshormon-freisetzende oxindolderivate
DD201782A5 (de) Verfahren zur herstellung von octahydro-1-(omega-mercaptoalkanoyl)-1h-indol 2-carbonsaeure-verbindungen
US3072530A (en) Therapeutic indoles for psychic stimulation and relief of mental depression
CS214800B2 (en) Method of preparation of substituted 4-hydroxypyrrolidine-2-ons
EP0769007A1 (en) 2-ureido-benzamide derivatives
EP0299493B1 (en) N-[(2-Oxopyrrolidin-1-yl)-acetyl]piperazine derivatives and drug for senile dementia
SU557758A3 (ru) Способ получени 4-азабензимидазолов или их солей
CH643554A5 (de) Verfahren zur herstellung von piperidinopropanolderivaten.
US3123618A (en) Io-dihydroanthkacene-z
SE435622B (sv) Terapeutisk komposition innehallande indolo(2,3-a)kinolizidiner
EP0282502A1 (de) Imidazol-derivate.
NO794272L (no) Fremgangsmaate for fremstilling av nye organiske forbindelser
DE2737630A1 (de) Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0062887A1 (de) Oxindol-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel mit neuroanaboler Wirkung
NO167863B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, kondenserte, heterocykliske tetrahydroaminokinolinoler.
EP0266308B1 (de) Indolo-pyrazino-benzodiazepin-Derivate
Taborsky et al. Synthesis and preliminary pharmacology of some 1-methylindoles
DE2559211A1 (de) Substituierte indole
DE69630184T2 (de) Verfahren zur Herstellung von 1-substituierten Pyrrol-3-carbonsäure-Derivaten
EP0412058A1 (en) 1-acyl-2-pyrrolidinones as enhancers of learning and memory and pharmaceutical compositions containing same
US4283410A (en) 3-Amino or amido-2-(1H-indol-3-yl) propanoic acid derivatives
EP0232675A1 (de) 5-Aminoalkyl-Beta-Carbolinderivate, ihre Herstellung und Verwendung als Arzneimittel
FI81782C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-styrensulfonyl-2-oxo-5-hydroxi-pyrrolidinderivat.